PATENT CLAIM ANALYSIS

Application Number: 15952058
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["548", "139000"]

Abstract:
The present disclosure relates generally to the use of methazolamide in therapy. The disclosure further relates to treating liver dysfunction, or improving liver function, in a patient.

Claim (Index 32):
The method of  claim 31 , wherein the dose of metformin is from 100 mg to 2000 mg per day.

Metadata:
- Claim Count in Document: 119.0
- Percentile: 91.0
- Lexical Diversity: 1.34783
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12524146', '14843873', '14775452', '15119695', '14863561']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7215129881338289
- 35 USC 102 Novelty (BERT): 0.5153196964584484
- Combined Prediction Score: 0.7008936589662909
- Mean Citation Score: 262.64834400000007
- Max Citation Score: 286.28256
- Similarity Product: 186.5222643261337

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test